Now, Netflix has a terrifying new series to add to the mix: Curon. Judging by reactions on Twitter, Curon, which has been rated as suitable for viewers aged 15 and over, has well and truly gotten ...

Now, it has bolted on a bispecific via a $1.3 billion licensing deal with Curon Biopharma. The big pharma is paying $700 million upfront for full global rights to CN201, a CD3xCD19 bispecific ...

Inc.’s stock fell 3% Thursday, after the drug company beat profit and sales estimates for the third quarter, but lowered ...